CORC

在结果中检索

CORC

浏览/检索结果: 共575条，第1-10条 帮助

限定条件    
已选(0)清除 条数/页：   排序方式：
Pseudo graph convolutional network for vehicle reid 会议论文
中国成都, 2021-10
作者:  Wen Qian;  Zhiqun He;  Silong Peng;  Chen Chen
收藏  |  浏览/下载：1/0  |  提交时间：2023/06/07
Research on Deep Learning Denoising Method in an Ultra-Fast All-Optical Solid-State Framing Camera 会议论文
Dublin, Ireland, 2021-07-19
作者:  Zhou, Jian;  Wang, Zhuping;  Wang, Tao;  Yang, Qing;  Wen, Keyao
收藏  |  浏览/下载：30/0  |  提交时间：2021/09/03
A Non-local Rank-Constraint Hyperspectral Images Denoising Method with 3-D Anisotropic Total Variation 会议论文
Phuket, Thailand, 2019-11-14
作者:  Gong, Tao;  Wen, Desheng;  He, Tianbin
收藏  |  浏览/下载：8/0  |  提交时间：2020/03/06
Gaussian process based neural architecture search. 会议论文
Washington State Convention Center, 2020 年 6 月 16 日 – 2020 年 6 月 18 日
作者:  Zhihang Li;  Teng Xi;  Jiankang Deng;  Gang Zhang;  Shengzhao Wen
收藏  |  浏览/下载：10/0  |  提交时间：2021/06/01
First Results of the IVU16 Prototype Undulator Measurements 会议论文
Australia, 2019
作者:  C. Yu;  Y.Z. He;  X. Hu;  Z. Jiang;  M.F. Qian
收藏  |  浏览/下载：37/0  |  提交时间：2019/08/06
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载：48/0  |  提交时间：2019/12/05
THE EFFICACY AND SAFETY OF RAVIDASVIR COMBINED WITH DANOPREVIR IN THE 12-WEEK ORAL REGIMEN FOR TREATMENT-NAIVE HCV GENOTYPE 1 ADULT PATIENTS WITHOUT CIRRHOSIS IN CHINA: PHASE II/III CLINICAL TRIAL 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Zheng, Sujun;  Guan, Yujuan;  Sheng, Jifang
收藏  |  浏览/下载：39/0  |  提交时间：2019/12/05
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载：40/0  |  提交时间：2019/12/05
THE EFFICACY AND SAFETY OF RAVIDASVIR COMBINED WITH DANOPREVIR IN THE 12-WEEK ORAL REGIMEN FOR TREATMENT-NAIVE HCV GENOTYPE 1 ADULT PATIENTS WITHOUT CIRRHOSIS IN CHINA: PHASE II/III CLINICAL TRIAL 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Zheng, Sujun;  Guan, Yujuan;  Sheng, Jifang
收藏  |  浏览/下载：33/0  |  提交时间：2019/12/05
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载：31/0  |  提交时间：2019/12/05

©版权所有 ©2017 CSpace - Powered by CSpace